Is Edwards Lifesciences Corp (NYSE: EW) Still On The Rise?

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Yahoo Finance discussed the stock recently as it posted Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Stocks Info

This NYSE-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $78.71 and fluctuated between $78.91 as its day high and $77.11 as its day low. The current market capitalization of Edwards Lifesciences Corp is $47.74B. A total of 5.0 million shares were traded on the day, compared to an average of 4.22M shares.

Insider Activity

Insider trades can also provide insight into a stock’s future direction. During the recent three months, EW has seen 4 BUY and 7 SELL insider trades, representing the acquisition of 415,699 and the disposition of 415,699 shares. Over the last 12 months, there were 86 BUYs and 111 SELLs from insiders. Insiders purchased 1,405,593 shares during that period but sold 1,256,134.

In the most recent transaction, Ullem Scott B. sold 7,255 shares of EW for 78.29 per share on Feb 01. After the transaction, the CVP, Chief Financial Officer now owns 19,248 company shares. In a previous transaction on Jan 12, BOBO DONALD E JR sold 10,000 shares at 75.67 per share. EW shares that CVP,Strategy/Corp Development owns now total 39,503.

Among the insiders who sold shares, MUSSALLEM MICHAEL A disposed of 29,350 shares on Jan 05 at a per-share price of $72.98. This resulted in the Director holding 4,486 shares of EW after the transaction. In another insider transaction, Ullem Scott B. sold 14,510 shares at $76.55 per share on Dec 29. Company shares held by the CVP, Chief Financial Officer now total 19,248.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for EW in the last 3 months, the mean price target is $79.41 with high estimates of $96.00 and low estimates of $57.00. In terms of 52-week highs and lows, EW has a high of $94.87 and a low of $60.57.

As of this writing, EW has an earnings estimate of $Edwards Lifesciences Corporatio per share for the current quarter. EPS was calculated based on a consensus of Energy Transfer LP estimates, with a high estimate of $Wayfair Inc. per share and a lower estimate of $EHang Holdings Limited.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. EW’s latest balance sheet shows that the firm has $1.47B in Cash & Short Term Investments as of fiscal 2021. There were $690.30M in debt and $1.03B in liabilities at the time. Its Book Value Per Share was $10.98, while its Total Shareholder’s Equity was $5.84B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EW is Buy with a score of 3.68.

Most Popular

Related Posts